{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T12:40:26Z","timestamp":1766407226045,"version":"3.37.3"},"reference-count":43,"publisher":"Informa UK Limited","issue":"1","funder":[{"DOI":"10.13039\/100019720","name":"GlaxoSmithKline Espa\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019720","id-type":"DOI","asserted-by":"publisher"}]},{"name":"IQVIA Espa\u00f1a"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Asthma"],"published-print":{"date-parts":[[2024,1,2]]},"DOI":"10.1080\/02770903.2023.2241905","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T11:58:34Z","timestamp":1690545514000},"page":"39-47","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Cost-effectiveness and resource use analysis of patients with asthma before and after treatment with mepolizumab in a real-life setting"],"prefix":"10.1080","volume":"61","author":[{"given":"Javier","family":"Dom\u00ednguez-Ortega","sequence":"first","affiliation":[{"name":"Department of Allergy, Hospital Universitario La Paz, Institute for Health Research (IdiPAZ), Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Laorden","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Hospital Universitario La Paz, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisca","family":"V\u00edlchez-S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Department of Allergy, Hospital Universitario La Paz, Institute for Health Research (IdiPAZ), Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Ba\u00f1as-Conejero","sequence":"additional","affiliation":[{"name":"Medical Department, GSK, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Quirce","sequence":"additional","affiliation":[{"name":"Department of Allergy, Hospital Universitario La Paz, Institute for Health Research (IdiPAZ), Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,8,12]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00202013"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s41030-019-00109-1"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2017-210531"},{"issue":"64","key":"e_1_3_4_5_1","first-page":"4639","article-title":"Prevalence, characterization and costs of severe asthma in Spain (BRAVO 1)","volume":"56","author":"Domingo Ribas C","year":"2020","unstructured":"Domingo Ribas C, Sogo Sagardia A, Prina E, Sicras Mainar A, Sicras Navarro A, Engroba Teijeiro C. Prevalence, characterization and costs of severe asthma in Spain (BRAVO 1). Eur Respir J. 2020;56(suppl 64):4639.","journal-title":"Eur Respir J"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2014.10.007"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200711-1754OC"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/clt2.12001"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/cea.13841"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.04.013"},{"key":"e_1_3_4_11_1","unstructured":"Nucala (Mepolizumab) [FichaT\u00e9cnica]. European Medicines Agency; Published December 2015. http:\/\/www.ema.europa.eu\/docs\/es_ES\/document_library\/EPAR__Product_Information\/human\/003860\/WC500198037.pdf [accessed 30 January 2019]."},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1403290"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(17)30125-X"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-021-01622-x"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/02770903.2021.1897835"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2022.05.042"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.03.042"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arbres.2023.05.007"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2016.10.028"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/02770903.2020.1837158"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2021.1941065"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arbres.2021.05.010"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0137-2019"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3003.1999.14a08.x"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-026742"},{"key":"e_1_3_4_26_1","volume-title":"Spanish health costs and cost-effectiveness ratios database: eSalud [Internet]","author":"Gisbert R","year":"2007","unstructured":"Gisbert R, Brosa M. Spanish health costs and cost-effectiveness ratios database: eSalud [Internet]. Barcelona: Oblikue Consulting, S.L.; 2007. http:\/\/www.oblikue.com\/bddcostes\/ [latest update: 2018; accessed 15 February 2022]."},{"key":"e_1_3_4_27_1","unstructured":"Consejo General de Colegios Oficiales de Farmac\u00e9uticos (CGCOF). Base de datos de medicamentos BotPlus 2.0; 2020. https:\/\/botplusweb.portalfarma.com\/."},{"key":"e_1_3_4_28_1","unstructured":"Instituto Nacional de Estad\u00edstica (INE). Nivel y condiciones de vida (IPC). https:\/\/www.ine.es\/dyngs\/INEbase\/categoria.htm?c=Estadistica_P&cid=1254735976604 [accessed 8 March 2022]."},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40733-016-0029-3"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-022-03339-0"},{"key":"e_1_3_4_31_1","doi-asserted-by":"crossref","unstructured":"Israel E Canonica GW Brusselle G Yang S Howarth PH Martin AL Koufopoulou M Smith SG Alfonso-Cristancho R. Real-life effectiveness of mepolizumab in severe asthma: a systematic literature review. J Asthma. 2022;59(11):2201\u20132217.","DOI":"10.1080\/02770903.2021.2008431"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.18176\/jiaci.0483"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/cea.14112"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.569500"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gaceta.2019.06.007"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1080\/02770903.2018.1499035"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arbres.2015.09.009"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S236609"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2020.1760285"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-018-0668-8"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737167.2017.1298444"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.4321\/S1135-57272015000600002"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.opresp.2022.100202"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1183156"}],"container-title":["Journal of Asthma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/02770903.2023.2241905","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T12:11:41Z","timestamp":1703851901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/02770903.2023.2241905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,12]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1,2]]}},"alternative-id":["10.1080\/02770903.2023.2241905"],"URL":"https:\/\/doi.org\/10.1080\/02770903.2023.2241905","relation":{},"ISSN":["0277-0903","1532-4303"],"issn-type":[{"type":"print","value":"0277-0903"},{"type":"electronic","value":"1532-4303"}],"subject":[],"published":{"date-parts":[[2023,8,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijas20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijas20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-01-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-24","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}